DISEASE CANCELLING
Dead / Abandoned — Abandoned — no statement of use filed (as of 07 Aug 2023)
What this means for you
This application is over — abandoned 07 Aug 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88718603
- Mark type
- Stylized text
- Filed
- 06 Dec 2019
- Published for opposition
- 10 Nov 2020
- Abandoned
- 07 Aug 2023
- Attorney of record
- Ian W. Gillies
Goods and services
- Class 005 — Pharmaceuticals: chemical preparations and reagents for pharmaceutical, medical, and medical clinical purposes, namely, for the prevention and treatment of cancer, diabetes, infectious diseases, autoimmune diseases and disorders, orthopedic diseases and disorders, blood diseases and disorders, fungal infections, diseases and disorders of the integumentary, muscular, skeletal, nervous, circulatory, lymphatic, respiratory, endocrine, urinary/excretory, reproductive and digestive systems, oncological diseases and disorders, and ophthalmological diseases and disorders; pharmaceuticals, pharmaceutical preparations and substances developed with a computer software platform using biology and chemistry analytics for the prevention and treatment of cancer, diabetes, infectious diseases, autoimmune diseases and disorders, orthopedic diseases and disorders, blood diseases and disorders, fungal infections, diseases and disorders of the integumentary, muscular, skeletal, nervous, circulatory, lymphatic, respiratory, endocrine, urinary/excretory, reproductive and digestive systems, oncological diseases and disorders, and ophthalmological diseases and disorders; pharmaceuticals, pharmaceutical preparations and substances for the prevention and treatment of cancer, diabetes, infectious diseases, autoimmune diseases and disorders, orthopedic diseases and disorders, blood diseases and disorders, fungal infections, diseases and disorders of the integumentary, muscular, skeletal, nervous, circulatory, lymphatic, respiratory, endocrine, urinary/excretory, reproductive and digestive systems, oncological diseases and disorders, and ophthalmological diseases and disorders
Owner
- Immuneering Corporation, Cambridge, MA, US
- Immuneering Corporation, Cambridge, MA, US
Prosecution history
- 07 Aug 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 07 Aug 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 20 Dec 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Dec 2022 — SOU EXTENSION 4 GRANTED
- 16 Dec 2022 — SOU EXTENSION 4 FILED
- 16 Dec 2022 — SOU TEAS EXTENSION RECEIVED
- 21 Jun 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jun 2022 — SOU EXTENSION 3 GRANTED
- 17 Jun 2022 — SOU EXTENSION 3 FILED
- 17 Jun 2022 — SOU TEAS EXTENSION RECEIVED
- 17 Dec 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Dec 2021 — SOU EXTENSION 2 GRANTED
- 15 Dec 2021 — SOU EXTENSION 2 FILED
- 15 Dec 2021 — SOU TEAS EXTENSION RECEIVED
- 08 Jul 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED